Using math to design vaccines of the future

A NEW VISION: EpiVax has pioneered the use of immune-informatics in the field of vaccine development. Here, research associate Ryan Tassone checks the efficacy of a vaccine on a group of cell cultures at the company’s Knowledge District lab. / PBN PHOTO/BRIAN MCDONALD
A NEW VISION: EpiVax has pioneered the use of immune-informatics in the field of vaccine development. Here, research associate Ryan Tassone checks the efficacy of a vaccine on a group of cell cultures at the company’s Knowledge District lab. / PBN PHOTO/BRIAN MCDONALD
EpiVax Inc., a biotech firm in Providence’s Knowledge District, is an innovator in the field of computational immunology, which involves feeding data into computers that apply mathematical approaches to ultimately develop vaccines and defeat disease. The company uses the pioneering concept of immuno-informatics to develop vaccines and therapeutics that will afford better protection against illness…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display